TP53 and breast cancer: For example, MAGE-A2 inhibits p53 ubiquitination and induces cell death (Marcar et al., 2015), and MAGE-D1 upregulates p53 and inhibits the proliferation and migration of breast cancer cells (Du et al., 2009).